Asthma and COPD Drugs Market: How Is Precision Medicine Transforming Asthma Phenotyping and Treatment Selection?
Precision medicine's application to asthma management — the molecular phenotyping of asthma into type 2-high (eosinophilic, allergic, aspirin-exacerbated respiratory disease) and type 2-low (neutrophilic, paucigranulocytic) endotypes using blood eosinophils, FeNO, allergen sensitization, and serum biomarkers enabling individualized treatment pathway selection — represents a...
0 Kommentare 0 Geteilt 14 Ansichten 0 Bewertungen